Literature DB >> 27036535

Effects of phosphodiester and phosphorothioate ODN2216 on leukotriene synthesis in human neutrophils and neutrophil apoptosis.

Galina M Viryasova1, Ekaterina A Golenkina1, Svetlana I Galkina1, Tatjana V Gaponova2, Yulia M Romanova3, Galina F Sud'ina4.   

Abstract

Polymorphonuclear leukocytes (PMNLs, neutrophils) play a major role in the initiation and resolution of the inflammatory response, and neutrophil apoptosis is a critical step in resolving inflammation. We examined the effects of oligodeoxynucleotide (ODN) species with different numbers of phosphodiester and phosphorothioate bonds on leukotriene synthesis in PMNLs and on neutrophil apoptosis. Our modifications were based on the well-known ODN2216 molecule (Krug et al., 2001). Treatment of cultured human neutrophils with ODN2216 accelerated apoptosis except in the case of a species with only phosphodiester bonds. The ODNs with poly(g) (phosphorothioate) sequences at both ends and a phosphodiester inner core had maximal effects on leukotriene synthesis in neutrophils and inhibited formation of 5-lipoxygenase metabolites. Addition of phosphodiester and phosphorothioate ODNs to PMNLs produced distinct effects on superoxide and nitric oxide formation: phosphorothioate-containing ODNs concomitantly stimulated production of nitric oxide and superoxide, which may rapidly combine to generate peroxynitrite. Altogether, our results describe strong activation of neutrophil's cellular responses by phosphorothioate ODN2216. We propose that phosphorothioate modification of ODNs represents a potential mechanism of PMNL activation.
Copyright © 2016 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  5-Lipoxygenase; Apoptosis; Neutrophil; Oligodeoxynucleotide

Mesh:

Substances:

Year:  2016        PMID: 27036535     DOI: 10.1016/j.biochi.2016.03.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9.

Authors:  Jelka Pohar; Duško Lainšček; Ana Kunšek; Miša-Mojca Cajnko; Roman Jerala; Mojca Benčina
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

2.  CpG-Oligodeoxynucleotides Alleviate Tert-Butyl Hydroperoxide-Induced Macrophage Apoptosis by Regulating Mitochondrial Function and Suppressing ROS Production.

Authors:  Yibai Qu; Chunxiu Yang; Xueyang Li; Haihua Luo; Shan Li; Mengwei Niu; Peng Chen; Zhengzheng Yan; Yong Jiang
Journal:  Oxid Med Cell Longev       Date:  2020-05-09       Impact factor: 6.543

3.  An optimized permeabilization step for flow cytometry analysis of nuclear proteins in myeloid differentiation of blood cells into neutrophils.

Authors:  G M Viryasova; E A Golenkina; V V Tatarskii; I I Galkin; G F Sud'ina; N V Soshnikova
Journal:  MethodsX       Date:  2019-02-15

4.  The Potential of Telomeric G-quadruplexes Containing Modified Oligoguanosine Overhangs in Activation of Bacterial Phagocytosis and Leukotriene Synthesis in Human Neutrophils.

Authors:  Ekaterina A Golenkina; Galina M Viryasova; Nina G Dolinnaya; Valeria A Bannikova; Tatjana V Gaponova; Yulia M Romanova; Galina F Sud'ina
Journal:  Biomolecules       Date:  2020-02-06

5.  Magic Peptide: Unique Properties of the LRR11 Peptide in the Activation of Leukotriene Synthesis in Human Neutrophils.

Authors:  Galina M Viryasova; Ekaterina A Golenkina; Tibor Hianik; Nataliya V Soshnikova; Nina G Dolinnaya; Tatjana V Gaponova; Yulia M Romanova; Galina F Sud'ina
Journal:  Int J Mol Sci       Date:  2021-03-06       Impact factor: 5.923

6.  Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming.

Authors:  Ekaterina A Golenkina; Svetlana I Galkina; Olga Pletjushkina; Boris Chernyak; Tatjana V Gaponova; Yulia M Romanova; Galina F Sud'ina
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.